Successful Pregnancy under Fibrinogen Substitution with Heparin and Aspirin in a Woman with Dysfibrinogenemia Revealed by Placental Abruption

Sylvie Bouvier; Mathias Chea; Sylvie Ripart; Michel Hanss; Philippe de Mazancourt; Jean-Christophe Gris

doi:10.1055/s-0038-1673615

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2018; 118(11): 2006-2008
DOI: 10.1055/s-0038-1673615

Letter to the Editor

Georg Thieme Verlag KG Stuttgart · New York

Successful Pregnancy under Fibrinogen Substitution with Heparin and Aspirin in a Woman with Dysfibrinogenemia Revealed by Placental Abruption

Sylvie Bouvier

¹Department of Haematology, Nîmes University Hospital, University of Montpellier, Nîmes, France

,

Mathias Chea

¹Department of Haematology, Nîmes University Hospital, University of Montpellier, Nîmes, France

,

Sylvie Ripart

²Department of Obstetrics and Gynaecology, Nîmes University Hospital, Nîmes, France

,

Michel Hanss

³Department of Haematology, University Hospital, Hospices Civils de Lyon, Bron, France

,

Philippe de Mazancourt

⁴UMR1179, University of Versailles St-Quentin, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris, Boulogne, France

,

Jean-Christophe Gris

¹Department of Haematology, Nîmes University Hospital, University of Montpellier, Nîmes, France

› Author Affiliations

Abstract

Full Text

References

References
1 Casini A, Neerman-Arbez M, Ariëns RA, de Moerloose P. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. J Thromb Haemost 2015; 13 (06) 909-919
2 Casini A, Blondon M, Lebreton A. , et al. Natural history of patients with congenital dysfibrinogenemia. Blood 2015; 125 (03) 553-561
3 Casini A, Undas A, Palla R, Thachil J, de Moerloose P. ; Subcommittee on Factor XIII and Fibrinogen. Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH. J Thromb Haemost 2018; 16 (09) 1887-1890
4 Hanss MML, Ffrench PO, Mornex JF. , et al. Two novel fibrinogen variants found in patients with pulmonary embolism and their families. J Thromb Haemost 2003; 1 (06) 1251-1257
5 Acharya SS, Dimichele DM. Rare inherited disorders of fibrinogen. Haemophilia 2008; 14 (06) 1151-1158
6 Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995; 73 (01) 151-161
7 Tiscia GL, Margaglione M. Human fibrinogen: molecular and genetic aspects of congenital disorders. Int J Mol Sci 2018; 19 (06) E1597
8 Paraboschi EM, Duga S, Asselta R. Fibrinogen as a pleiotropic protein causing human diseases: the mutational burden of Aα, Bβ, and γ chains. Int J Mol Sci 2017; 18 (12) E2711
9 Collen A, Maas A, Kooistra T. , et al. Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aalpha-chain, alters endothelial capillary tube formation. Blood 2001; 97 (04) 973-980
10 Tajdar M, Orlando C, Casini A. , et al. Heterozygous FGA p.Asp473Ter (fibrinogen Nieuwegein) presenting as antepartum cerebral thrombosis. Thromb Res 2018; 163: 185-189
11 Iwaki T, Sandoval-Cooper MJ, Paiva M, Kobayashi T, Ploplis VA, Castellino FJ. Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse. Am J Pathol 2002; 160 (03) 1021-1034
12 Pike GN, Bolton-Maggs PH. Factor deficiencies in pregnancy. Hematol Oncol Clin North Am 2011; 25 (02) 359-378
13 Takala T, Oksa H, Rasi V, Tuimala R. Dysfibrinogenemia associated with thrombosis and third-trimester fetal loss. A case report. J Reprod Med 1991; 36 (05) 410-412
14 Edwards RZ, Rijhsinghani A. Dysfibrinogenemia and placental abruption. Obstet Gynecol 2000; 95 (6 Pt 2): 1043
15 Yamanaka Y, Takeuchi K, Sugimoto M, Sato A, Nakago S, Maruo T. Dysfibrinogenemia during pregnancy treated successfully with fibrinogen. Acta Obstet Gynecol Scand 2003; 82 (10) 972-973
16 Miesbach W, Scharrer I, Henschen A, Neerman-Arbez M, Spitzer S, Galanakis D. Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects. Blood Coagul Fibrinolysis 2010; 21 (01) 35-40
17 Peyvandi F. Epidemiology and treatment of congenital fibrinogen deficiency. Thromb Res 2012; 130 (Suppl. 02) S7-S11
18 Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104 (05) 1243-1252
19 Franchini M, Raffaelli R, Musola M. , et al. Management of inherited dysfibrinogenemia during pregnancy: a description of four consecutive cases. Ann Hematol 2007; 86 (09) 693-694